Literature DB >> 27226208

Enhanced Physical Activity Improves Selected Outcomes in Children With ADHD: Systematic Review.

MinKyoung Song1, Deborah Lauseng2, Soohee Lee2, Megan Nordstrom2, Victor Katch2.   

Abstract

This review examines associations between physical activity (PA) and cognitive, behavioral, and physiological outcomes in children with attention-deficit/hyperactivity disorder (ADHD). We reviewed studies on participants ≤18 years old, published in English between January 1998 and December 2014, in PubMed, CINAHL, PsycINFO, and Cochrane Reviews. Twenty-six studies were grouped into two categories: those that did and did not account for effects of ADHD medications. The first category showed lower levels of PA and improved cognitive and behavioral outcomes in youth whose ADHD was treated with medications. The second category showed a positive association between PA levels and cognitive and behavioral outcomes in youth whose ADHD was not treated with medications. For both categories of studies, results were inconclusive regarding physiological outcomes. Randomized controlled trials are needed to better clarify the relationship between PA and outcomes in youth with ADHD, and particularly to understand the impact of ADHD medications on that relationship.
© The Author(s) 2016.

Entities:  

Keywords:  attention-deficit/hyperactivity disorder; children; physical activity

Mesh:

Year:  2016        PMID: 27226208      PMCID: PMC9112868          DOI: 10.1177/0193945916649954

Source DB:  PubMed          Journal:  West J Nurs Res        ISSN: 0193-9459            Impact factor:   1.774


  52 in total

Review 1.  Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Authors:  Laurence L Greenhill; Steven Pliszka; Mina K Dulcan; William Bernet; Valerie Arnold; Joseph Beitchman; R Scott Benson; Oscar Bukstein; Joan Kinlan; Jon McClellan; David Rue; Jon A Shaw; Saundra Stock
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-02       Impact factor: 8.829

2.  Sports therapy for attention, cognitions and sociality.

Authors:  K D Kang; J W Choi; S G Kang; D H Han
Journal:  Int J Sports Med       Date:  2011-11-08       Impact factor: 3.118

3.  Stimulant medications decrease energy expenditure and physical activity in children with attention-deficit/hyperactivity disorder.

Authors:  N F Butte; M S Treuth; R G Voigt; A M Llorente; W C Heird
Journal:  J Pediatr       Date:  1999-08       Impact factor: 4.406

4.  Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder.

Authors:  B J Casey; F X Castellanos; J N Giedd; W L Marsh; S D Hamburger; A B Schubert; Y C Vauss; A C Vaituzis; D P Dickstein; S E Sarfatti; J L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-03       Impact factor: 8.829

Review 5.  Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  G Bjornstad; P Montgomery
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

6.  Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder.

Authors:  Philip Shaw; Meaghan Malek; Bethany Watson; Wendy Sharp; Alan Evans; Deanna Greenstein
Journal:  Biol Psychiatry       Date:  2012-03-13       Impact factor: 13.382

7.  Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial.

Authors:  Kerstin Konrad; Thomas Günther; Monika Heinzel-Gutenbrunner; Beate Herpertz-Dahlmann
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-04       Impact factor: 2.576

Review 8.  Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Andrea M Chronis; Heather A Jones; Veronica L Raggi
Journal:  Clin Psychol Rev       Date:  2006-02-17

9.  Exercise improves behavioral, neurocognitive, and scholastic performance in children with attention-deficit/hyperactivity disorder.

Authors:  Matthew B Pontifex; Brian J Saliba; Lauren B Raine; Daniel L Picchietti; Charles H Hillman
Journal:  J Pediatr       Date:  2012-10-17       Impact factor: 4.406

10.  Drug therapy of attention deficit hyperactivity disorder: current trends.

Authors:  Avinash De Sousa; Gurvinder Kalra
Journal:  Mens Sana Monogr       Date:  2012-01
View more
  6 in total

Review 1.  Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.

Authors:  Nora L Nock; Sonia Minnes; Jay L Alberts
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

2.  The Relationship Between Antioxidants and Inflammation in Children With Attention Deficit Hyperactivity Disorder.

Authors:  Iman Namjoo; Amirmansour Alavi Naeini; Mostafa Najafi; Mohammad Reza Aghaye Ghazvini; Akbar Hasanzadeh
Journal:  Basic Clin Neurosci       Date:  2020-05-01

3.  The Influence of Health Behaviours in Childhood on Attention Deficit and Hyperactivity Disorder in Adolescence.

Authors:  Xiuyun Wu; Arto Ohinmaa; Paul J Veugelers
Journal:  Nutrients       Date:  2016-12-02       Impact factor: 5.717

Review 4.  ADHD: a critical update for educational professionals.

Authors:  Sanne Te Meerman; Laura Batstra; Hans Grietens; Allen Frances
Journal:  Int J Qual Stud Health Well-being       Date:  2017-06

5.  A Life-Long Approach to Physical Activity for Brain Health.

Authors:  Helen Macpherson; Wei-P Teo; Luke A Schneider; Ashleigh E Smith
Journal:  Front Aging Neurosci       Date:  2017-05-23       Impact factor: 5.750

6.  Relationship between Health-Related Quality of Life and Physical Activity in Children with Hyperactivity.

Authors:  Julio Gallego-Méndez; Jorge Perez-Gomez; José Ignacio Calzada-Rodríguez; Ángel Manuel Denche-Zamorano; María Mendoza-Muñoz; Jorge Carlos-Vivas; Miguel Ángel Garcia-Gordillo; Jose C Adsuar
Journal:  Int J Environ Res Public Health       Date:  2020-04-18       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.